Skip to main content
Fig. 1 | BMC Immunology

Fig. 1

From: Downregulation of NKG2DLs by TGF-β in human lung cancer cells

Fig. 1

Decrease surface expression levels of some kinds of NKG2DLs by treatment with TGF-β. The surface expression levels of NKG2DLs were showed as histograms and graphs in (A) NCI-H23, (B) SW-900 and (C) A549 lung cancer cells, which were treated with TGF-β (10 ng/ml, 20 ng/ml) for 24 h. A representative data was shown. The relative expression ratios were calculated from mean fluorescence intensities (MFI) of treated cells compared to those of control cells. Filled gray, dotted gray, gray and black lines represent isotype, media control, TGF-β 10 ng/ml treatment and TGF-β 20 ng/ml treatment, respectively. The experiments were performed three times. (p < 0.05, *; p < 0.01, **)

Back to article page